Global Microneedle Drug Delivery Systems Market to reach USD 8.0 Billion by 2027.Global Microneedle Drug Delivery Systems Market is valued approximately at USD 5.57 Billion in 2020 and is anticipated to grow with a healthy growth rate of more than 5.3% over the forecast period 2021-2027. Microneedles can be used for delivering a pretreatment in pore formation to the skin. The microneedles penetrate into scrape of the skin to make holes through which the drugs can transport. The global Microneedle Drug Delivery Systems market is being driven by rising demand for a safer substitute to conventional hypodermic injections and increase in prevalence of diabetic cases across the world. Furthermore, rising technological advancement will provide a new opportunity in the forecasted period. For instance. According to IDF diabetes atlas edition, 2019 around 463 adults were living with diabetes which will rise to 700 million adults by 2045. As a result, increase in prevalence of diabetes patients across the world will serve as a catalyst for the industry in the future. However, limited number of approved products and complications/risks associated with microneedles may impede market growth over the forecast period of 2021-2027.
Asia Pacific, North America, Europe, Latin America, and Rest of the World are the key region considered for the global Microneedle Drug Delivery Systems Market.Among these region North America is the leading region owing to factors such as strong government initiatives and support for development of healthcare sector, increase in awareness for the rare disorders and availability of good quality medical facility . Whereas Asia pacific is also anticipated to exhibit the highest growth rate over the forecast period 2021-2027, owing to factors such as rising geriatric population and growth in investment in healthcare sector.
Major market player included in this report are:
Raphas
Novartis International AG
Becton, Dickinson and Company
B. Braun
Nanopass Technologies Limited
Termo
Smiths Medical
Cardinal Health
3M
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product Type:
Solid
Hollow
Dissolving
Coated
Others
By Material:
Silicon
Metal
Polymer
Others
By End use:
Dermatology
Hormone delivery
Pain management
Cancer therapy
Vaccine delivery
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019
Base year - 2020
Forecast period - 2021 to 2027.
Target Audience of the Global Microneedle Drug Delivery Systems Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
